BSEBoard Meeting28 Oct 2026 · 28 Oct 2026, 12:42 pm
Anthem Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial results of the Company for the quarter and half year ended September 30, 2026
Anthem Biosciences Ltd · 544449
✦ AI SummaryResults
Anthem Biosciences Ltd has scheduled a board meeting on November 3, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Anthem Biosciences Ltd - 544449 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026
Attachments (1)
📄pdf
Download →
401c0eac-d7f7-42e0-8623-039c5ef1cb0f.pdf
View document text
Date: October 28, 2026
BSE Limited, National Stock Exchange of India Limited
20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex, Bandra (E),
Mumbai - 400001. Mumbai – 400 051
BSE Scrip Code: 544449 NSE Scrip Symbol: ANTHEM
Subject: Intimation of the Board Meeting, pursuant to Regulation 29 of Securities and Exchange Board
of India (Listing Obligations and Disclosure Requirement) Regulations, 2015
Dear Sir/Ma’am
This is to inform you that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of
Anthem Biosciences Limited (“the Company”) is scheduled to be held on Tuesday, November 03,
2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results
for the quarter and half year ended September 30, 2026.
In furtherance to our previous letter dated September 24, 2026, the trading window for dealing in Equity
Shares of the Company has been closed from October 01, 2026 till close of trading hours of November
05, 2026 i.e. until 48 (Forty-Eight) hours after the declaration of the financial results of the Company
for the quarter and half year ended September 30, 2026, in compliance with the SEBI (Prohibition of
Insider Trading) Regulations, 2015 and Company’s Code of Conduct to regulate, monitor, and report
trading by Employees and other Connected person.
The above intimation is also available on the Company’s website at https://anthembio.com/.
We request you to kindly take the same on record.
Thanking you,
Yours truly,
For Anthem Biosciences Limited
(Formerly known as Anthem Biosciences Private Limited)
Divya Prasad
Company Secretary & Compliance Officer
Membership No: A41438